The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
- PMID: 26935559
- DOI: 10.1016/j.eururo.2016.02.029
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Abstract
The fourth edition of the World Health Organization (WHO) classification of urogenital tumours (WHO "blue book"), published in 2016, contains significant revisions. These revisions were performed after consideration by a large international group of pathologists with special expertise in this area. A subgroup of these persons met at the WHO Consensus Conference in Zurich, Switzerland, in 2015 to finalize the revisions. This review summarizes the most significant differences between the newly published classification and the prior version for renal, penile, and testicular tumours. Newly recognized epithelial renal tumours are hereditary leiomyomatosis and renal cell carcinoma (RCC) syndrome-associated RCC, succinate dehydrogenase-deficient RCC, tubulocystic RCC, acquired cystic disease-associated RCC, and clear cell papillary RCC. The WHO/International Society of Urological Pathology renal tumour grading system was recommended, and the definition of renal papillary adenoma was modified. The new WHO classification of penile squamous cell carcinomas is based on the presence of human papillomavirus and defines histologic subtypes accordingly. Germ cell neoplasia in situ (GCNIS) of the testis is the WHO-recommended term for precursor lesions of invasive germ cell tumours, and testicular germ cell tumours are now separated into two fundamentally different groups: those derived from GCNIS and those unrelated to GCNIS. Spermatocytic seminoma has been designated as a spermatocytic tumour and placed within the group of non-GCNIS-related tumours in the 2016 WHO classification.
Patient summary: The 2016 World Health Organization (WHO) classification contains new renal tumour entities. The classification of penile squamous cell carcinomas is based on the presence of human papillomavirus. Germ cell neoplasia in situ of the testis is the WHO-recommended term for precursor lesions of invasive germ cell tumours.
Keywords: Male genital organs; Urogenital tract; WHO classification.
Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Pathology and Genetics: Tumours of the Urinary System and Male Genital System: Clinical Implications of the 4th Edition of the WHO Classification and Beyond.Eur Urol. 2016 Jul;70(1):120-123. doi: 10.1016/j.eururo.2016.03.011. Epub 2016 Mar 17. Eur Urol. 2016. PMID: 26996660 No abstract available.
Similar articles
-
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.Eur Urol. 2022 Nov;82(5):458-468. doi: 10.1016/j.eururo.2022.06.016. Epub 2022 Jul 16. Eur Urol. 2022. PMID: 35853783 Review.
-
The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel.Histopathology. 2017 Feb;70(3):335-346. doi: 10.1111/his.13102. Epub 2016 Dec 14. Histopathology. 2017. PMID: 27747907 Review.
-
The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations.Histopathology. 2018 May;72(6):893-904. doi: 10.1111/his.13429. Epub 2018 Feb 9. Histopathology. 2018. PMID: 29105175 Review.
-
[International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia 2012].Cesk Patol. 2014;50(4):137-41. Cesk Patol. 2014. PMID: 25418900 Czech.
-
[Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].Pathologe. 2015 May;36(3):310-6. doi: 10.1007/s00292-014-2030-z. Pathologe. 2015. PMID: 25398389 German.
Cited by
-
Long non-coding RNA LUCAT1 promotes the progression of clear cell renal cell carcinoma via the microRNA-375/YAP1 axis.Exp Ther Med. 2021 Jul;22(1):754. doi: 10.3892/etm.2021.10186. Epub 2021 May 12. Exp Ther Med. 2021. PMID: 34035851 Free PMC article.
-
Clinical Features and Prognostic Outcome of Renal Collecting Duct Carcinoma: 12 Cases from a Single Institution.Cancer Manag Res. 2020 May 19;12:3589-3595. doi: 10.2147/CMAR.S244094. eCollection 2020. Cancer Manag Res. 2020. PMID: 32547196 Free PMC article.
-
IL13Rα2 Is Involved in the Progress of Renal Cell Carcinoma through the JAK2/FOXO3 Pathway.J Pers Med. 2021 Apr 8;11(4):284. doi: 10.3390/jpm11040284. J Pers Med. 2021. PMID: 33917914 Free PMC article.
-
Development and validation of a nomogram incorporating multi-parametric MRI and hematological indicators for discriminating benign from malignant central prostatic nodules: a retrospective analysis.Am J Transl Res. 2024 Jul 15;16(7):2921-2930. doi: 10.62347/RBCM8913. eCollection 2024. Am J Transl Res. 2024. PMID: 39114671 Free PMC article.
-
Contribution and Expression of Organic Cation Transporters and Aquaporin Water Channels in Renal Cancer.Rev Physiol Biochem Pharmacol. 2021;181:81-104. doi: 10.1007/112_2020_34. Rev Physiol Biochem Pharmacol. 2021. PMID: 32772272 Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous